Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers
Cannabis Law Report
JULY 28, 2021
We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” Epub 2010 Dec 17.
Let's personalize your content